|1.||Exanthema Subitum (Roseola Infantum)
|3.||Encephalitis (Encephalitis, Rasmussen)
|4.||Febrile Seizures (Febrile Seizure)
|1.||Yavarian, Jila: 2 articles (09/2014 - 04/2014)|
|2.||Mamishi, Setareh: 2 articles (09/2014 - 04/2014)|
|3.||Agut, Henri: 1 article (04/2015)|
|4.||Bonnafous, Pascale: 1 article (04/2015)|
|5.||Gautheret-Dejean, Agnès: 1 article (04/2015)|
|6.||Gavvami, Nastaran: 1 article (09/2014)|
|7.||Kamrani, Laura: 1 article (04/2014)|
|8.||Mohammadpour, Masoud: 1 article (04/2014)|
|9.||Illiaquer, Marina: 1 article (02/2014)|
|10.||Bressollette-Bodin, Céline: 1 article (02/2014)|
01/01/1996 - "Our study also confirmed that antibodies are acquired very early in life in the same age group as exanthema subitum does."
05/23/1992 - "33 of them already had HHV-6 antibodies in their first blood sample although their history was negative concerning exanthema subitum. "
01/01/1992 - "Twenty-five patients with clinical exanthema subitum (roseola infantum) were enrolled into a study, where acute-phase and convalescent sera were examined for antibodies to human herpesvirus 6 (HHV-6), several other viruses, and other microbes. "
06/01/1991 - "[Seroprevalence of antibodies to human herpesvirus 6 (exanthema subitum; critical 3-day fever-exanthema in young children) in the population of Northern Germany]."
01/01/1990 - "Prevalence of antibodies to human herpesvirus 6 in different age groups, in children with exanthema subitum, other acute exanthematous childhood diseases, Kawasaki syndrome, and acute infections with other herpesviruses and HIV."
|2.||DNA (Deoxyribonucleic Acid)IBA
10/01/1996 - "The degree of DNA homology between variants ranges from 97% in the most conserved region to 75% in the immediate early region 1. HHV-6B is the etiologic agent of exanthema subitum but HHV-6A has not yet been clearly associated with any human pathology. "
09/01/2014 - "The aim of this study was detection of human herpesvirus-6 (HHV-6) DNA in cerebrospinal fluid (CSF) of patients with symptoms of possible acute encephalitis and without typical signs or symptoms of roseola infantum, using real-time polymerase chain reaction (PCR). "
04/01/2014 - "The objective of this study was to determine the prevalence of HHV-6 by detecting DNA in cerebrospinal fluid (CSF) of children with febrile convulsion and without any rash of roseola infantum. "
|3.||Interleukin-6 (Interleukin 6)IBA
|5.||Immunoglobulin M (IgM)IBA
12/01/1990 - "The data suggest that there are clinical syndromes in addition to roseola infantum associated with the presence of IgM anti-HHV6, in which serological screening for evidence of acute HHV6 infection may be useful."
09/01/1991 - "Exanthema subitum was described in 1910 by John Zahorsky/USA; in 1986 and 1988 the human herpesvirus 6 (HHV 6) was discovered as the causative agent of the disease and serologic tests were established for diagnostics (specific IgM and IgG antibodies). "
|6.||Polychlorinated Biphenyls (PCBs)IBA
|7.||Penicillins (Penicillin)FDA Link
05/28/1971 - "[Penicillin allergy or exanthema subitum?]."
|8.||Immunoglobulin G (IgG)IBA
|1.||Transplantation (Transplant Recipients)
04/01/2015 - "As emblematic examples of HHV-6 pathogenicity, exanthema subitum, a benign disease of infancy, is associated with primary infection, whereas further virus reactivations can induce severe encephalitis cases, particularly in hematopoietic stem cell transplant recipients. "
12/01/2008 - "Human herpesvirus-6 (HHV-6) has been identified as the causal agent of exanthema subitum in early childhood (also called sixth disease or roseola), a mononucleosis-like disease in adults, and as an opportunistic pathogen in transplant recipients. "
|2.||Stem Cell Transplantation
|3.||Hematopoietic Stem Cell Transplantation